HAL : inserm-00691415, version 1

PubMed : 21695162

PubMed Central : 3114750

DOI : 10.1371/journal.pntd.0001197

Fiche détaillée

Récupérer au format BibTeX - EndNote - TEI - RefWorks -

PLoS Neglected Tropical Diseases 5, 6 (2011) e1197

The Chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study.

Man-Koumba Soumahoro (  Auteur correspondant ) 1, 2, Pierre-Yves Boelle 1, 3, Bernard-Alex Gaüzere 4, Kokuvi Atsou 1, Camille Pelat 1, Bruno Lambert 5, Guy La Ruche 6, Marc Gastellu-Etchegorry 6, Philippe Renault 7, Marianne Sarazin 1, Yazdan Yazdanpanah 8, Antoine Flahault 1, Denis Malvy 9, Thomas Hanslik 1, 10

(06/2011)

BACKGROUND: This study was conducted to assess the impact of chikungunya on health costs during the epidemic that occurred on La Réunion in 2005-2006. METHODOLOGY/PRINCIPAL FINDINGS: From data collected from health agencies, the additional costs incurred by chikungunya in terms of consultations, drug consumption and absence from work were determined by a comparison with the expected costs outside the epidemic period. The cost of hospitalization was estimated from data provided by the national hospitalization database for short-term care by considering all hospital stays in which the ICD-10 code A92.0 appeared. A cost-of-illness study was conducted from the perspective of the third-party payer. Direct medical costs per outpatient and inpatient case were evaluated. The costs were estimated in Euros at 2006 values. Additional reimbursements for consultations with general practitioners and drugs were estimated as € 12.4 million (range: € 7.7 million-€ 17.1 million) and € 5 million (€ 1.9 million-€ 8.1 million), respectively, while the cost of hospitalization for chikungunya was estimated to be € 8.5 million (€ 5.8 million-€ 8.7 million). Productivity costs were estimated as € 17.4 million (€ 6 million-€ 28.9 million). The medical cost of the chikungunya epidemic was estimated as € 43.9 million, 60% due to direct medical costs and 40% to indirect costs (€ 26.5 million and € 17.4 million, respectively). The direct medical cost was assessed as € 90 for each outpatient and € 2,000 for each inpatient. CONCLUSIONS/SIGNIFICANCE: The medical management of chikungunya during the epidemic on La Réunion Island was associated with an important economic burden. The estimated cost of the reported disease can be used to evaluate the cost/efficacy and cost/benefit ratios for prevention and control programmes of emerging arboviruses.

1 :	Epidémiologie des maladies infectieuses et modélisation (ESIM)
	INSERM : U707 – Université Pierre et Marie Curie [UPMC] - Paris VI
2 :	Département d'Epidémiologie-Recherche Clinique
	Institut Pasteur de Côte d'Ivoire
3 :	Pôle de Pharmacie - Santé Publique - Information médicale [Saint-Antoine]
	Hôpital Saint-Antoine – Assistance publique - Hôpitaux de Paris (AP-HP) – Université Pierre et Marie Curie [UPMC] - Paris VI
4 :	Service de microbiologie
	CHR La réunion – Groupe Hospitalier Sud
5 :	IMS-Health
	IMS-Health
6 :	Institut de Veille Sanitaire
	INVS
7 :	CIRE Océan Indien
	ARS Océan Indien
8 :	Inflammation: mécanismes et régulation et interactions avec la nutrition et les candidoses
	INSERM : U995
9 :	Service de médecine interne et maladies tropicales
	CHU Bordeaux – Groupe hospitalier Saint-André
10 :	Service de médecine interne [Paré]
	Assistance publique - Hôpitaux de Paris (AP-HP) – Hôpital Ambroise Paré – Université de Versailles Saint-Quentin-en-Yvelines

domaine

:

Sciences du Vivant/Médecine humaine et pathologie/Maladies infectieuses

inserm-00691415, version 1

http://www.hal.inserm.fr/inserm-00691415

oai:www.hal.inserm.fr:inserm-00691415

Contributeur : Delphine Autard <>

Soumis le : Jeudi 26 Avril 2012, 10:54:41

Dernière modification le : Jeudi 26 Avril 2012, 10:56:35